Background: Chlamydial infections are common among young women
C hlamydia trachomatis is the most common notifiable disease in the United States. In 2016, there were 1,072,719 reported infections among women. 1 Untreated infections can lead to serious reproductive health complications, such as pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and infertility. [2] [3] [4] [5] Persons with chlamydial infections are usually asymptomatic, 3, 6 so infections are often not detected or reported. 6 This underscores the importance of early detection and treatment for existing chlamydial infections, and prevention efforts to avoid new infections (eg, expedited partner therapy, risk reduction counseling). [7] [8] [9] As such, annual screening is recommended for all sexually active women younger than 25 years and older women at increased risk for infection, and those who test positive for chlamydia should be screened again 3 months after treatment to detect repeat infections. 2, 10 Women, who are younger and of a racial/ethnic minority group, are disproportionately affected by high rates of chlamydia. 1 In 2016, the rate of reported chlamydial infections for young women aged 15 to 24 years in the United States was 3070.9 to 3779.0 per 100,000, almost 5-fold higher than the overall national female rate of 657.3 per 100,000. Of note, young black women aged 15 to 24 years had the highest rate of chlamydial infections (6485.2-6747.6 per 100,000) compared with all other racial/ ethnic and age groups. In fact, the rate of reported cases among black women was 5.1 times the rate among white women according to the latest US surveillance report. 1 Racial/ethnic disparities have been noted elsewhere in the literature. [11] [12] [13] Repeat infections are common and can affect as many as 1 in 5 women treated for chlamydial infection within the previous year. 14, 15 Although risk of repeat chlamydial infections among women has been previously assessed, differences in study design, length of follow-up, and country or population characteristics have yielded variable results. 13, 14, [16] [17] [18] Repeat infection rates can be underestimated if women who are not retested are considered uninfected, or overestimated if only retested women are included, and symptomatic women are more likely to be retested. Evaluation of repeat infections by subgroups could help elucidate populations at high risk who could benefit from targeted public health prevention efforts. In Louisiana, which has the second highest chlamydia rate in the country, 1 black women comprise only 17% of the population but account for 52% of all chlamydial infections reported in the state. 19, 20 Using surveillance data, we assessed the risk of repeat chlamydial infections reported among young women in Louisiana and time interval between infections by age and race/ethnicity.
MATERIALS AND METHODS
For this retrospective cohort study, we obtained surveillance data on all chlamydial infections reported among women in Louisiana from January 1, 2000, to December 31, 2015. Infection with C. trachomatis is directly detected by culture or, most commonly, by nucleic acid amplification testing. 1, 3 Laboratories and/or physicians report positive test results to their local or state health department. 21 Health departments remove duplicate case reports before submitting the information to the Centers for Disease Control and Prevention to be compiled into national surveillance reports.
Data were deidentified but unique profile numbers specific to each woman allowed us to match multiple records for the same person in lieu of not having names, addresses, or other identifying information. Women aged 15 to 34 years at first infection were censored after they had a repeat infection or after 3 years of follow-up, whichever came first. Chlamydial infections reported more than 30 days after a previous positive test were considered new incident infections because repeat testing less than 4 weeks after completing therapy is often false positive due to detection of residual nucleic acid from nonviable bacteria. 2 We examined the (1) cumulative incidence of repeat chlamydial infection and (2) incidence rate of repeat chlamydial infection among women by calendar year of the first reported infection for 2000 to 2012. The year 2012 was the maximum limit to allow 3 years of potential follow-up through 2015. The cumulative incidence describes the probability or risk of an outcome over a specific period. Thus, the cumulative incidence of a repeat infection over a 3-year period was estimated by dividing the number of repeat infections reported at least 30 days from the first positive test by the total number of women first diagnosed with chlamydial infection in the respective year. Women were considered to be uninfected if no subsequent positive test was reported. Next, since the incidence rate is a measure of the number of new cases per unit of time, we calculated rates for each year by dividing the number of women with repeat infections reported within 3 years of their first positive report by the number of total person-years (PY) of follow up. Given the high morbidity in Louisiana, all rates were expressed as the number of repeat infections per 100 PY.
To explore risk of repeat infections among various subgroups, we evaluated the incidence and rate of repeat infection by race (white, black, other, and unknown) age group 22,23 Lastly, we assessed timing of repeat chlamydial infection from the first reported infection (ie, ≤3 months, ≤6months,≤12 months, ≤24 months, and ≤36 months) by race and age. Because of the small sample size in other racial/ ethnic groups, age-specific estimates were obtained for only white and black women. The Centers for Disease Control and Prevention made the determination that this study was not human subject research and would be exempted from review by the institutional review board because it used routinely collected surveillance data after personal identifiers were removed. The percentage of women with repeat infections within 3 years of the first infection and incidence rate of repeat chlamydial infections increased over time for women of all racial/ethnic and age groups ( Table 1) . At each year of interest (ie, 2000, 2007, and 2012), black women had the highest risk of repeat infection. In 2012, the rate of repeat infection for black women (14.6 per 100 PY) was 1.8 times the rate among white women (8.1 per 100 PY), and 1.5 times the rate among women of other racial/ ethnic groups (9.6 per 100 PY). Age at first infection was inversely related to the risk of having a repeat chlamydial infection regardless of race/ethnicity. The risk of a repeat infection among white women aged 15 to 19 years was 28.8%, whereas for those aged 25 to 29 years, it was 13.8%. The risk of repeat infection among black women was 44.4% for 15 to 19 year olds and 16.9% for 25 to 29 year olds.
RESULTS

From
Overall, the risk of chlamydial repeat infection increased as the duration of time since the first infection increased (Fig. 2) . In 2012, the proportion of women with repeat infection within 3 months was higher in young black women (6.8%) than young white women (5.1%) aged 15 to 19 years. However, among older women, the risk of repeat infection was slightly higher among white women in the first few months after the first infection. Over longer periods, the risk of repeat infection was more pronounced among black women. A repeat chlamydial infection by 12 months was more common among young black women aged 15 to 19 years (white) and 9.5% (black). In addition, the time between infections was shorter among black women than white women. For instance, the risk of repeat infection for black women at 12 months or less (17.8%) was akin to the risk for white women at 24 months or less (17.6%, data not shown). Similar findings were observed for black women at 6 months or less (10.4%) and white women at 12 months or less (11.7%).
DISCUSSION
Young women diagnosed with chlamydia in Louisiana were at high risk for having another reported chlamydial infection. Among 15-to 34-year-old women, 1 in 4 had a repeat infection in 3 years or less. Repeat infection rates were highest among young 15-to 19-year-old black women, of which 44.4% had a repeat chlamydial infection within 3 years. Repeat chlamydial infections continued to be diagnosed throughout the 3-year follow-up periods. This is consistent with the findings from another study that estimated the cumulative risk of chlamydial infection among young women in Florida. 13 Based on surveillance data, approximately 25% of 15-to 20-year-old women who were initially infected in 2000 to 2003 had a repeat chlamydial infection within 3 years. It is notable that these and current study findings underestimate the true risk of repeat infection because retesting rates are often low. 14, 16, 18 Only about a quarter of women who test positive for chlamydia are retested at 3 months, as recommended, and many are not tested annually. 24 Furthermore, asymptomatic chlamydial infections can clear within months without treatment and could be easily missed without timely and frequent testing. 25 Previous studies have reported repeat infection rates as high as 26.5% over a 12-month period in diverse populations although not all removed chlamydial infections reported less than 30 days after a previous positive test, and the proportion of women who were retested ranged from 26% to 93% or was not reported.
14 In a US-based, multicenter, randomized controlled trial of patientdelivered partner treatment among women aged 14 to 34 years (1996-2000), the cumulative rate of repeat chlamydial infection was 12% (87/728 intervention group) and 15% (108/726 control group) 4 months after treatment. 26 More recently, a retrospective cohort study from New Zealand reported 5.9% of 4139 women infected with chlamydia at baseline had a repeat infection within 6 months; however, positivity increased to 17.5% when restricted to only women who were retested (n = 1454). 16 Similarly, a randomized controlled trial of retesting intervals in the Netherlands found 69 people assigned to be retested 26 weeks after treatment for urogenital chlamydia had a repeat infection, which was 14.4% of 478 retested or 9.3% of 745 assigned to be retested. 17 Thus, additional and frequent testing beyond the currently recommended 3-month rescreening may be warranted for women with chlamydia.
Repeat chlamydial infection rates were especially high among young black women in our analysis. One study that assessed repeat infections among women aged 16 to 24 years entering the National Job Training Program found little difference between blacks (6.1% of 3210 retested) and whites (4.9% of 1006 retested) who retested positive for chlamydia 1 to 2 months after treatment (odds ratio [OR], 1.3; 95% confidence interval [CI], 0.9-1.8). However, black women were significantly less likely to get retested compared to their white counterparts (OR, 0.4; 95% CI, 0.4-0.5). 27 Low retesting among black women (39.4% vs. 59.4% whites) could have underestimated the true repeat infection rate and attenuated disparities by race. Racial disparities in chlamydia and other sexually transmitted infections (STIs) have been well documented and are attributed to a wide range of sociodemographic, environmental, behavioral, and social factors. [28] [29] [30] However, pronounced racial disparities have persisted even after controlling for risk behaviors and other individual level factors. 28, 29 In a recent study of the Longitudinal Survey of Adolescent Health, race remained significantly associated with chlamydia independent of sociodemographic characteristics, access to health care, and risky sexual behavior (OR, 5.2; 
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Sexually Transmitted Diseases • Volume 46, Number 1, January 201995% CI, 3.8-7.2 for non-Hispanic blacks). 29 In addition, the structure of local sexual networks like partner concurrency and assortative mixing by race disproportionately affects populations with high underlying prevalence of STIs from which sexual partners are selected. 29 Repeat testing is necessary for all women positive for chlamydia, who are at increased risk of repeat infection and adverse health sequelae. 31 and more sensitive diagnostic tests. 3 Our trends in repeat chlamydial infection mirror the findings for all infections in the general population. 11, 12 One study using population-based data from the National Health and Nutrition Examination Survey 11 Though reasons for persistent disparities in positivity and leveled trends in recent years are not clear, the high proportion of repeat infections underscore the need for better targeted screening and primary prevention efforts, particularly for women at high risk for having repeat chlamydial infections.
There is low adherence to repeat testing in various clinical settings 24, 27 ; however, little is known about the impact of provider characteristics or sources of care on repeat infections. One study that assessed reported STIs (ie, chlamydial, gonorrhea, syphilis) in Massachusetts during 2014 to 2016 found 44% of cases with 5 or more STIs were diagnosed within the same health care system with shared access to clinical and laboratory information. 32 This highlights potential opportunities for providers to retest women for repeat infections, get their partners tested and treated, and discuss primary prevention strategies (eg, condoms and other barrier contraceptive methods) tailored to women's preferences to prevent subsequent repeat infections. 2 Partner dynamics should be considered and is particularly relevant to women unable to negotiate male condom use. The impact of provider communication on sexual health outcomes is not well understood, but a qualitative study of contraceptive counseling in family planning clinics found attention to sexual behavior patterns and STI risk was largely absent during patient-provider interactions. 33 Future studies could evaluate how content and quality of provider communication reduces repeat chlamydial infections and other STIs among women. Provider characteristics associated with repeat screening could also be assessed.
This study had several limitations. We examined populationbased trends in reported chlamydia in Louisiana that spanned almost 2 decades; however, chlamydial repeat infection rates were likely underestimated. We only had positive test results so we could not measure rescreening rates. Although improved provider knowledge of screening guidelines could potentially lead to increased detection of repeat infections, studies have shown that people are not retested frequently enough to catch all chlamydial infections. 14, 16, 18 Repeat infection rates can be underestimated if women who are not retested are considered uninfected. Thus, the true repeat infection rates could have been substantially higher. Data entry errors of patient information (eg, name, date of birth, profile number) could have also underestimated the number of repeat infections if records for the same person were counted as infections from different individuals. It was assumed that all reported cases were treated, and infections occurring more than 30 days after the first infection were incident events; however, untreated cases or treatment failures may have led to overestimation of the number of repeat infections. Repeat chlamydial infection trends in the beginning of the study period (eg, 2000) could have included women with 1 or more infections prior to 2000 particularly among older age groups. When women with previous infections were included in recent years (ie, any person with a reported infection in a year), repeat infection rates increased among older women (data not shown). Thus, the overall increase in repeat chlamydial infections from 2000 to 2012 would have been greater than we estimated. Chlamydia testing technology also changed during this time resulting in more sensitive tests, so early incidence rates are likely to underestimate true rates.
High rates of repeat chlamydia were reported among young women in Louisiana. The true number of repeat infections is likely higher because surveillance data only count infections that were detected and reported. Current recommendations state that women who test positive for chlamydia should be rescreened 3 months after treatment to detect new repeat infections. However, we found that the majority of new repeat infections occurred after 3 months. Our findings suggest that additional testing after 3 months may be helpful. Routine visits for sexual or reproductive health services provide apt opportunities for clinicians and other health workers to detect asymptomatic infections and discuss risk reduction strategies (eg, expedited partner therapy, barrier contraceptive methods). 7, 9, 34 Strategies to improve adherence to repeat testing could include standing orders, phone reminders, and mailed screening test kits. [35] [36] [37] Low condom use among young women at risk for STIs highlights the importance for health promotion and program activities to emphasize dual prevention of STI and unintended pregnancy. 38 A flexible and comprehensive approach to STI prevention is needed to address high rates of repeat infections among women.
